GFAP versus S100B in serum after traumatic brain injury: Relationship to brain damage and outcome

被引:228
|
作者
Pelinka, LE
Kroepfl, A
Leixnering, M
Buchinger, W
Raabe, A
Redl, H
机构
[1] Ludwig Boltzmann Inst Expt & Clin Traumatol, A-1200 Vienna, Austria
[2] Austrian Workers Compensat Board, Res Unit, AUVA, Vienna, Austria
[3] AUVA, Trauma Hosp Linz, Linz, Austria
[4] Waldviertel Clin, Dept Traumatol, Horn, Austria
[5] Goethe Univ Frankfurt, Dept Neurosurg, Neuroctr, D-6000 Frankfurt, Germany
关键词
computerized tomography; GFAP; intracranial pressure; neuromarkers; perfusion pressure; S100B protein;
D O I
10.1089/0897715042441846
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Research indicates that glial fibrillary acidic protein (GFAP), part of the astroglial skeleton, could be a marker of traumatic brain injury (TBI). S100B, an astroglial protein, is an acknowledged marker of TBI. Our goal was to analyze the relationship of GFAP/S100B to brain damage and outcome, and to compare the accuracy of GFAP/S100B for prediction of mortality after TBI. Our prospective study included 92 patients admitted <12 h after TBI (median injury severity score 25, median Glasgow Coma Scale 6). TBI was verfied by computerized tomography. GFAP/S100B were measured immunoluminometrically at admission and daily in the intensive care unit (average 10 days, range 1-21 days). We compared GFAP/S100B in non-survivors versus survivors, accuracy for mortality prediction according to receiver operated characteristic curve analysis, correlation between GFAP and S100B, relationship of GFAP/S100B to computerized tomography, cerebral perfusion pressure (CPP), mean arterial pressure (MAP) and 3-month Glasgow Outcome Score (GOS). GFAP (p < 0.005) and S100B (p < 0.0005) were higher in non-survivors than survivors. Both GFAP and S100B were accurate for mortality prediction (area under curve 0.84 versus 0.78 at <12 h after TBI). GFAP and S100B release correlated better later than 36 h after TBI (r = 0.75) than earlier (r = 0.58). GFAP was lower in focal lesions of <25 mL than in shifts of >0.5 cm (P < 0.0005) and non-evacuated mass lesions of >25 mL (p < 0.005). S100B was lower in focal lesions of <25 mL than in non-evacuated mass lesions (p < 0.0005) and lower in swelling than in shifts of >0.5 cm (p < 0.005). GFAP and S100B were lower in ICP < 25 than ICP greater than or equal to 25 (p < 0.0005), in CPP greater than or equal to 60 than CPP < 60 (p < 0.0005), in MAP > 70 than MAP:5 70 nun Hg, and in GOS 4-5 than GOS 1 (p < 0.0005). Both measurement of GFAP and S100B is a useful non-invasive means of identifying brain damage with some differences based on the pattern of TBI and accompanying multiple trauma and/or shock.
引用
收藏
页码:1553 / 1561
页数:9
相关论文
共 50 条
  • [41] Is Salivary S100B a Biomarker of Traumatic Brain Injury? A Pilot Study
    Janigro, Damir
    Kawata, Keisuke
    Silverman, Erika
    Marchi, Nicola
    Diaz-Arrastia, Ramon
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [42] S100B protein, a precursor biomarker of mild traumatic brain injury
    Beaudeux, Jean-Louis
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2024, 208 (06): : 832 - 842
  • [43] Serial measurement of S100B and NSE in pediatric traumatic brain injury
    Park, Dae-Won
    Park, Seong-Hyun
    Hwang, Sung-Kyoo
    CHILDS NERVOUS SYSTEM, 2019, 35 (02) : 343 - 348
  • [44] Diagnostic values of proenkephalin and S100B protein in traumatic brain injury
    Yalcin, Anil
    Baydin, Ahmet
    Tuncel, Ozgur Korhan
    Erenler, Ali Kemal
    Cokluk, Cengiz
    Guzel, Murat
    Tomak, Leman
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2017, 41 (03): : 123 - 128
  • [45] Prediction of neuropsychological outcome after mild traumatic brain injury using clinical parameters, serum S100B protein and findings on computed tomography
    Heidari, Kamran
    Asadollahi, Shadi
    Jamshidian, Morteza
    Abrishamchi, Shohreh Nasiri
    Nouroozi, Mahdi
    BRAIN INJURY, 2015, 29 (01) : 33 - 40
  • [46] Role of S100B protein in urine and serum as an early predictor of mortality after severe traumatic brain injury in adults
    Rodriguez-Rodriguez, Ana
    Jose Egea-Guerrero, Juan
    Leon-Justel, Antonio
    Gordillo-Escobar, Elena
    Revuelto-Rey, Jaume
    Vilches-Arenas, Angel
    Carrillo-Vico, Antonio
    Maria Dominguez-Roldan, Jose
    Murillo-Cabezas, Francisco
    Miguel Guerrero, Juan
    CLINICA CHIMICA ACTA, 2012, 414 : 228 - 233
  • [47] S100B IN SERUM AND CEREBROSPINAL FLUID DOES NOT CORRELATE WITH OUTCOME FOLLOWING ACUTE BRAIN INJURY
    Schmidt, Christian
    Xu, Yu
    Emtmann, Irene
    Parsch, Hans
    Buchfelder, Michael
    Kleindienst, Andrea
    JOURNAL OF NEUROTRAUMA, 2009, 26 (08) : A76 - A76
  • [48] NEURON-SPECIFIC ENOLASE IS SIGNIFICANTLY CORRELATED TO OUTCOME POST TRAUMATIC BRAIN INJURY, ALBEIT NOT IN PRESENCE OF SERUM S100B
    Thelin, Eric
    Jeppsson, Emma
    Nelson, David
    Mondello, Stefania
    Svensson, Mikael
    Bellander, Bo-Michael
    JOURNAL OF NEUROTRAUMA, 2015, 32 (12) : A30 - A30
  • [49] Role of the S100B serum biomarker in the treatment of children suffering from mild traumatic brain injury
    Filippidis, Aristotelis S.
    Papadopoulos, Dimitrios C.
    Kapsalaki, Eftychia Z.
    Fountas, Kostas N.
    NEUROSURGICAL FOCUS, 2010, 29 (05) : 1 - 5
  • [50] The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury
    Jiří Žurek
    Michal Fedora
    Acta Neurochirurgica, 2012, 154 : 93 - 103